Ming Teh D Chen, MD
Gynecological Oncology · Mountain View
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 11
- 2 carriers
- Offices
- 9
- Since medical school
- 39 years
- George Washington University School of Medicine, 1987
Offices
9 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Hospitals listed: El Camino Health · Mills-Peninsula Medical Center. That is not proof they admit you there this week.
Plans that list them
11 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Chen’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
11 of 11 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Sutter Advantage +More (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence G64782 · Current
Licensed to practise in California · since 1988 · expires 2028-07-31 · George Washington University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Obstetrics and Gynecology - Gynecologic Oncology
- American Board of Obstetrics and Gynecology - Obstetrics and Gynecology
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
- Peninsula Medical CenterBurlingame, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 78% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.139, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.242, Oct 2024 – Sep 2025
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Peninsula Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.139 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.242 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.21 (0.27 to 2.15) · 1,258 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.81 (0.51 to 1.1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 155.44 (112.67 to 198.21) · 90 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.5 · 32 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 82 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10 · 188 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9 · 473 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.8 · 342 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.4 · 485 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 3,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.4) · 6,904 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.4) · 7,052 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.41 (1.43 to 5.39) · 1,695 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.72 (0.17 to 3.28) · 665 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,545 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.1 (1.3 to 12.9) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.96 (2.63 to 9.29) · 653 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.15 to 3.08) · 418 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.14 (0 to 0.78) · 5,539 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.7 · 192 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.215 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.263 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.74 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.3 · 300 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19 · 702 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 1.2 · 207 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -13.6 · 531 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 24.3 · 343 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.1 · 449 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.5 (2.8 to 7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9.6 (6.7 to 13.7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.7 · 189 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11 · 45 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.6 · 117 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (9.7 to 17.2) · 584 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 764 cases | No different | Jan 2024 – Dec 2024 |
What patients said (523 patients answered, 27% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$117,612
Medicare paid this office $117,612 for 214 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Removal of uterus, tubes, and/or ovaries through abdomen using an endoscope, 250.0 g or less | 38 | $31,339 | $825 |
| Short return visit (20+ min) | 116 | $11,579 | $82 |
| New patient visit (60+ min) | 51 | $10,092 | $198 |
| Return visit (30+ min) | 48 | $9,917 | $118 |
| Biopsy and removal of lymph nodes of abdominal cavity using an endoscope | 18 | $4,210 | $234 |
See all 8 services
| Removal of uterus, tubes, and/or ovaries through abdomen using an endoscope, 250.0 g or less | 38 | $31,339 | $825 |
| Short return visit (20+ min) | 116 | $11,579 | $82 |
| New patient visit (60+ min) | 51 | $10,092 | $198 |
| Return visit (30+ min) | 48 | $9,917 | $118 |
| Biopsy and removal of lymph nodes of abdominal cavity using an endoscope | 18 | $4,210 | $234 |
| Imaging of lymph nodes during surgery | 18 | $2,543 | $141 |
| New patient visit (45+ min) | 14 | $2,232 | $159 |
| Long return visit (40+ min) | 12 | $1,899 | $158 |
Procedures Medicare counted
| Colonoscopy | 1-10 | None |
| Removal of the uterus | 58 | More than 99% of doctors who do this |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Removal of uterus, tubes, and/or ovaries through abdomen using an endoscope, 250.0 g or less | 40 | 54 | 40 | 41 | 38 | 38 |
| Imaging of lymph nodes during surgery | 41 | 44 | 27 | 29 | 31 | 18 |
| Biopsy and removal of lymph nodes of abdominal cavity using an endoscope | 37 | 42 | 27 | 26 | 27 | 18 |
| Removal of uterus, tubes, and/or ovaries through abdomen using an endoscope, more than 250.0 g | 14 | – | – | – | – | – |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
214 Original Medicare patients in 2024. Average age 75 · Also on Medicaid 6% · Health risk score 1.17. At or below the middle of the specialty; the typical gynecological oncology clinician is at 1.53.
Conditions among them: High blood pressure 61% · Cancer 51% · Diabetes 19% · Chronic kidney disease 17% · Atrial fibrillation 14% · Depression 14% · Coronary heart disease 10% · Heart failure 7% · Stroke 7% · COPD 6%.
The office billed $550,301, Medicare allowed $150,066 and paid $117,612; for 455 services of 57 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 214 | 455 | 75 | 1.17 | $550,301 | $117,612 |
| 2023 | 213 | 490 | 74 | 1.17 | $554,896 | $119,459 |
| 2022 | 230 | 551 | 74 | 1.07 | $612,977 | $143,658 |
| 2021 | 199 | 507 | 73 | 1.17 | $568,653 | $136,851 |
| 2020 | 211 | 518 | 74 | 1.40 | $657,197 | $155,028 |
| 2019 | 251 | 647 | 73 | 1.39 | $817,610 | $184,918 |
| 2018 | 244 | 616 | 72 | 1.33 | $829,249 | $175,033 |
| 2017 | 263 | 629 | 73 | 1.38 | $763,340 | $170,819 |
| 2016 | 241 | 572 | 73 | 1.44 | $736,909 | $164,288 |
| 2015 | 229 | 704 | 73 | 1.28 | $669,753 | $162,762 |
| 2014 | 251 | 651 | 73 | 1.29 | $720,681 | $175,662 |
| 2013 | 246 | 679 | 73 | 1.32 | $772,442 | $186,653 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 8 services
| Removal of uterus, tubes, and/or ovaries through abdomen using an endoscope, 250.0 g or less | 38 | $30,421 | $801 |
| Short return visit (20+ min) | 125 | $11,960 | $77 |
| New patient visit (60+ min) | 46 | $9,275 | $202 |
| Return visit (30+ min) | 39 | $7,386 | $117 |
| Biopsy and removal of lymph nodes of abdominal cavity using an endoscope | 27 | $6,434 | $238 |
| Imaging of lymph nodes during surgery | 31 | $5,459 | $176 |
| New patient visit (45+ min) | 19 | $3,022 | $159 |
| Long return visit (40+ min) | 19 | $3,014 | $159 |
2022: 8 services
| Removal of uterus, tubes, and/or ovaries through abdomen using an endoscope, 250.0 g or less | 41 | $34,265 | $836 |
| New patient visit (60+ min) | 75 | $15,218 | $203 |
| Short return visit (20+ min) | 125 | $13,019 | $81 |
| Return visit (30+ min) | 55 | $10,149 | $121 |
| Biopsy and removal of lymph nodes of abdominal cavity using an endoscope | 26 | $6,196 | $238 |
| Imaging of lymph nodes during surgery | 29 | $5,059 | $174 |
| New patient visit (45+ min) | 19 | $3,051 | $161 |
| New patient visit (30+ min) | 19 | $2,061 | $108 |
2021: 7 services
| Removal of uterus, tubes, and/or ovaries through abdomen using an endoscope, 250.0 g or less | 40 | $33,030 | $826 |
| New patient visit (60+ min) | 56 | $11,885 | $212 |
| Short return visit (20+ min) | 115 | $11,825 | $79 |
| Return visit (30+ min) | 34 | $7,772 | $127 |
| Biopsy and removal of lymph nodes of abdominal cavity using an endoscope | 27 | $6,734 | $249 |
| Imaging of lymph nodes during surgery | 27 | $4,924 | $182 |
| New patient visit (30+ min) | 17 | $1,713 | $101 |
2020: 6 services
| Removal of uterus, tubes, and/or ovaries through abdomen using an endoscope, 250.0 g or less | 54 | $45,069 | $835 |
| New patient visit (45+ min) | 91 | $13,909 | $153 |
| Biopsy and removal of lymph nodes of abdominal cavity using an endoscope | 42 | $10,090 | $240 |
| Short return visit (20+ min) | 99 | $8,100 | $67 |
| Imaging of lymph nodes during surgery | 44 | $7,710 | $175 |
| Return visit (30+ min) | 48 | $6,262 | $101 |
2019: 8 services
| Removal of uterus, tubes, and/or ovaries through abdomen using an endoscope, 250.0 g or less | 40 | $31,857 | $796 |
| Removal of uterus, tubes, and/or ovaries through abdomen using an endoscope, more than 250.0 g | 14 | $15,311 | $1,094 |
| New patient visit (45+ min) | 98 | $15,038 | $153 |
| Short return visit (20+ min) | 132 | $11,182 | $64 |
| Biopsy and removal of lymph nodes of abdominal cavity using an endoscope | 37 | $8,870 | $240 |
| Return visit (30+ min) | 54 | $8,278 | $102 |
| Imaging of lymph nodes during surgery | 41 | $7,193 | $175 |
| New patient visit (30+ min) | 18 | $1,826 | $101 |
2018: 7 services
| Removal of uterus, tubes, and/or ovaries through abdomen using an endoscope, more than 250.0 g | 51 | $53,928 | $1,057 |
| New patient visit (45+ min) | 84 | $12,373 | $147 |
| Short return visit (20+ min) | 131 | $10,148 | $60 |
| Biopsy and removal of lymph nodes of abdominal cavity using an endoscope | 37 | $8,435 | $228 |
| Return visit (30+ min) | 43 | $6,527 | $100 |
| New patient visit (30+ min) | 23 | $2,337 | $102 |
| Other procedure on lymphatic system | 20 | $363 | $18 |
2017: 8 services
| Removal of uterus, tubes, and/or ovaries through abdomen using an endoscope, more than 250.0 g | 50 | $52,499 | $1,050 |
| New patient visit (45+ min) | 86 | $12,327 | $143 |
| Short return visit (20+ min) | 142 | $11,422 | $61 |
| Biopsy and removal of lymph nodes of abdominal cavity using an endoscope | 31 | $6,873 | $222 |
| Return visit (30+ min) | 44 | $5,269 | $96 |
| New patient visit (60+ min) | 20 | $3,638 | $182 |
| New patient visit (30+ min) | 18 | $1,622 | $90 |
| Injection of radioactive material for x-ray identification of lymph node | 33 | $626 | $19 |
2016: 7 services
| Removal of uterus, tubes, and/or ovaries through abdomen using an endoscope, more than 250.0 g | 34 | $35,882 | $1,055 |
| Short return visit (20+ min) | 132 | $11,162 | $60 |
| New patient visit (45+ min) | 70 | $10,512 | $150 |
| Return visit (30+ min) | 52 | $8,591 | $94 |
| Removal of ovaries and/or tubes using an endoscope | 11 | $6,309 | $574 |
| New patient visit (60+ min) | 17 | $3,220 | $189 |
| New patient visit (30+ min) | 18 | $1,598 | $89 |
2015: 6 services
| Removal of uterus, tubes, and/or ovaries through abdomen using an endoscope, more than 250.0 g | 35 | $38,132 | $1,089 |
| New patient visit (45+ min) | 72 | $10,882 | $151 |
| Short return visit (20+ min) | 128 | $10,770 | $60 |
| Return visit (30+ min) | 45 | $8,248 | $104 |
| Removal of lymph nodes of both sides of pelvis and abdominal lymph node biopsy using an endoscope | 11 | $5,451 | $496 |
| New patient visit (30+ min) | 14 | $1,488 | $106 |
2014: 6 services
| Removal of uterus, tubes, and/or ovaries through abdomen using an endoscope, more than 250.0 g | 37 | $43,958 | $1,188 |
| Short return visit (20+ min) | 157 | $15,004 | $60 |
| New patient visit (45+ min) | 75 | $10,865 | $145 |
| Removal of lymph nodes of both sides of pelvis and abdominal lymph node biopsy using an endoscope | 18 | $8,958 | $498 |
| Return visit (30+ min) | 50 | $6,754 | $96 |
| New patient visit (60+ min) | 23 | $4,333 | $188 |
2013: 6 services
| Removal of uterus, tubes, and/or ovaries through abdomen using an endoscope, more than 250.0 g | 39 | $45,998 | $1,179 |
| Short return visit (20+ min) | 144 | $12,145 | $60 |
| New patient visit (45+ min) | 76 | $11,106 | $146 |
| Removal of lymph nodes of both sides of pelvis and abdominal lymph node biopsy using an endoscope | 17 | $8,003 | $471 |
| Return visit (30+ min) | 65 | $7,478 | $88 |
| New patient visit (30+ min) | 15 | $1,399 | $93 |
Drugs they prescribed that Part D paid
$1,397
Pharmacies billed $1,397 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
33 generic and fewer than 11 brand-name prescriptions · $1,397 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Letrozole | 12 | $171 | $14 |
Year by year
| 2024 | 34 | 18 | None | None | $1,397 |
| 2023 | 71 | 34 | None | None | $3,879 |
| 2022 | 69 | 24 | None | None | $2,097 |
| 2021 | 55 | 21 | None | 22% | $136,508 |
| 2020 | 72 | 27 | None | None | $20,859 |
| 2019 | 108 | 43 | None | 16% | $43,956 |
| 2018 | 113 | 37 | None | None | $3,773 |
| 2017 | 116 | 48 | 12% (14) | 9% | $5,671 |
| 2016 | 160 | 62 | 11% (17) | 19% | $10,424 |
| 2015 | 207 | 73 | 9% (18) | None | $32,262 |
| 2014 | 141 | 71 | 25% (35) | 21% | $15,913 |
| 2013 | 105 | 57 | 26% (27) | None | $10,801 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 2 drugs
| Megestrol Acetate | 14 | $571 | $41 |
| Letrozole | 19 | $537 | $28 |
2022: 2 drugs
| Megestrol Acetate | 22 | $266 | $12 |
| Imiquimod | 13 | $214 | $16 |
2021: 2 drugs
| Letrozole | 13 | $453 | $35 |
| Megestrol Acetate | 11 | $40 | $4 |
2019: 2 drugs
| Tamoxifen Citrate | 11 | $1,145 | $104 |
| Megestrol Acetate | 13 | $455 | $35 |
2018: 2 drugs
| Tamoxifen Citrate | 12 | $1,079 | $90 |
| Megestrol Acetate | 16 | $492 | $31 |
2017: 2 drugs
| Megestrol Acetate | 27 | $869 | $32 |
| Hydrocodone-Acetaminophen | 11 | $68 | $6 |
2016: 2 drugs
| Xarelto | 11 | $3,905 | $355 |
| Megestrol Acetate | 28 | $1,001 | $36 |
2015: 6 drugs
| Xarelto | 12 | $3,910 | $326 |
| Suprep | 32 | $2,583 | $81 |
| Letrozole | 23 | $1,173 | $51 |
| Duloxetine | 11 | $1,047 | $95 |
| Megestrol Acetate | 16 | $339 | $21 |
| Lorazepam | 15 | $231 | $15 |
2014: 3 drugs
| Imiquimod | 14 | $4,734 | $338 |
| Duloxetine | 11 | $1,553 | $141 |
| Hydrocodone-Acetaminophen | 26 | $313 | $12 |
2013: 1 drug
| Hydrocodone-Acetaminophen | 22 | $257 | $12 |
Money from drug and device companies
$244 in 2025
| 2025 | 2 | 2 | None | $244 |
| 2024 | 2 | 3 | None | $391 |
| 2023 | 2 | 3 | None | $154 |
| 2022 | 5 | 14 | None | $1,104 |
| 2021 | 1 | 1 | None | $38 |
| 2020 | 3 | 3 | None | $160 |
| 2019 | 9 | 13 | None | $453 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Eisai | Lenvima | $124 | 1 payment
|
| Myriad Genetic Laboratories | Precisetumor | $120 | 1 payment
|
See all 2 published payments
| Myriad Genetic Laboratories | Meals · 2025-04-29 | Precisetumor | $120 |
| Eisai | Meals · 2025-03-14 | Lenvima | $124 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $391
| Intuitive Surgical | Da Vinci Surgical System | $266 | 2 payments
|
| Pfizer | Tivdak | $125 | 1 payment
|
2023: $154
| Myriad Genetic Laboratories | Precisetumor | $80 | 1 payment
|
| Intuitive Surgical | Da Vinci Surgical System | $74 | 2 payments
|
2022: $1,104
| Conmed | Airseal | $490 | 5 payments
|
| Intuitive Surgical | Da Vinci Surgical System | $253 | 6 payments
|
| AstraZeneca Pharmaceuticals LP | Lynparza | $124 | 1 payment
|
| Myriad Genetic Laboratories | Mychoice Cdx | $123 | 1 payment
|
| GlaxoSmithKline | Zejula | $114 | 1 payment
|
2021: $38
| Myriad Genetic Laboratories | Mychoice Cdx | $38 | 1 payment
|
2020: $160
| Merck Sharp & Dohme | Keytruda | $125 | 1 payment
|
| Janssen Biotech | Darzalex | $18 | 1 payment
|
| Celgene | Pomalyst | $17 | 1 payment
|
2019: $453
| Applied Medical Resources | None | $129 | 1 payment
|
| Intuitive Surgical | Da Vinci Surgical System | $115 | 2 payments
|
| Takeda Pharmaceuticals U.S.A. | None | $77 | 3 payments
|
| Celgene | Revlimid | $32 | 2 payments
|
| Rigel Pharmaceuticals | Tavalisse | $25 | 1 payment
|
| Janssen Biotech | Darzalex | $24 | 1 payment
|
| Merck Sharp & Dohme | Keytruda | $19 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Imfinzi | $17 | 1 payment
|
| Incyte | Jakafi | $14 | 1 payment
|
Professional record
- NPI
- 1174543334
- Licence
- CA G64782California G64782: Current · expires 2028-07-31
- Trained
- George Washington University School of Medicine, 1987 · 39 years ago
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207VX0201X (207VX0201X)
- Mailing address
- 325 Distel Cir, Los Altos, CA, 94022
- NPI first listed
- 2006-07-20
- NPI last updated
- 2020-01-23
- NPI record certified
- 2020-01-23
This is when the NPI record was last certified, not a medical board exam.